Mass spectrometry‐based method for quantification of nimodipine and glutamate in cerebrospinal fluid: pilot study with patients after aneurysmal subarachnoid haemorrhage

This study describes the range of nimodipine and glutamate values in CSF following aSAH. Technical aspects for nimodpine and glutamate measurement in CSF using a developed LC/MS/MS method.

Saved in:
Bibliographic Details
Main Authors: Mindt, Sonani (Author) , Tokhi, Ursala (Author) , Hedtke, Maren (Author) , Groß, Hans-Jürgen (Author) , Hänggi, Daniel (Author)
Format: Article (Journal)
Language:English
Published: 2020
In: Journal of clinical pharmacy and therapeutics
Year: 2020, Volume: 45, Issue: 1, Pages: 81-87
ISSN:1365-2710
DOI:10.1111/jcpt.13028
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/jcpt.13028
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/10.1111/jcpt.13028
Get full text
Author Notes:Sonani Mindt, Ursala Tokhi, Maren Hedtke, Hans-Jürgen Groß, Daniel Hänggi
Description
Summary:This study describes the range of nimodipine and glutamate values in CSF following aSAH. Technical aspects for nimodpine and glutamate measurement in CSF using a developed LC/MS/MS method.
Item Description:First published: 17 August 2019
Gesehen am 26.01.2021
Physical Description:Online Resource
ISSN:1365-2710
DOI:10.1111/jcpt.13028